Charles Cohen's Net Worth

$11.1 Million

Estimate Recalculated Mar 25, 2024 06:32PM EST

Who is Charles Cohen?

Charles Cohen has an estimated net worth of $11.1 Million. This is based on reported shares across multiple companies, which include EXELIXIS, INC., ANESIVA, INC., ANADYS PHARMACEUTICALS INC, and ALGORX PHARMACEUTICALS INC.

SEC CIK

Charles Cohen's CIK is 0001202089

Past Insider Trading and Trends

2020 was Charles Cohen's most active year for acquiring shares with 6 total transactions. Charles Cohen's most active month to acquire stocks was the month of April. 2007 was Charles Cohen's most active year for disposing of shares, totalling 15 transactions. Charles Cohen's most active month to dispose stocks was the month of May. 2020 saw Charles Cohen paying a total of $897,804.72 for 236,146 shares, this is the most they've acquired in one year. In 2019 Charles Cohen cashed out on 279,701 shares for a total of $5,611,817.18, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EXELIXIS, INC. (EXEL) Snapshot price: $20.205

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+44.11%
80K
$4.72
$377,200.00
261.38K
Jul 6
Form 4
—
0
—
—
0
May 27
Form 4
—
0
$13.04
-$772,400.00
181.38K
Feb 24
Form 4
+174.90%
115.4K
$5.82
$671,604.72
181.38K
Sep 1
Form 4
—
0
—
—
0
May 21
Form 4
+214.50%
45K
$5.03
$226,200.00
65.98K
Feb 28
Form 4
—
0
—
—
0
May 23
Form 4
∞
20.98K
$13.29
-$1,560.78
20.98K
Feb 25
Form 4
-100.00%
-248.18K
$22.14
-$5,494,906.40
0
Feb 14 - Feb 19
Form 4
—
0
—
—
0
May 24
Form 4
—
0
$16.54
-$146,400.00
248.18K
May 9
Form 4
—
0
$16.10
-$243,900.00
248.18K
Mar 5
Form 4
—
0
—
—
0
May 25
Form 4
+4.20%
10K
$10.53
$105,300.00
248.18K
Mar 27
Form 4
-4.03%
-10.00K
$21.82
-$218,200.00
238.18K
Mar 13
Form 4
—
0
—
—
0
May 26
Form 4
+5.90%
13.83K
—
—
248.18K
Jan 4
Form 4
—
0
—
—
0
May 28
Form 4
+37.35%
63.73K
—
—
234.35K
Oct 14
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
Dec 6
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
May 2
Form 4
-4.55%
-8.13K
$12.06
-$97,987.50
170.63K
Scheduled
Oct 11
Form 4
-4.35%
-8.13K
$12.30
-$99,937.50
178.75K
Scheduled
Jul 2
Form 4
-4.17%
-8.13K
$12.06
-$98,004.75
186.88K
Scheduled
Jun 21
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
Apr 23
Form 4/A
—
0
—
—
0
Apr 9
Form 4
—
0
—
—
0
Apr 9
Form 4
—
0
—
—
0
No matching records found

ANESIVA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Jun 22
Form 4
∞
1.92K
—
—
1.92K
Dec 15 - Dec 16
Form 3
—
0
—
—
0
No matching records found

ANADYS PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

ALGORX PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found